As demonstrated before, even in aged mice tumour outgrowth was substantially diminished by donor OT-II cells primed concomitantly with IL-6 blockade when endogenous CD8+ T cells were retained (Fig. 7a). This evidence concerns the gene CD8A and neoplasm.